P22933
PR
Gene name |
Gabrd |
Protein name |
Gamma-aminobutyric acid receptor subunit delta |
Names |
GABA(A) receptor subunit delta |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:14403 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P22933
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P22933-F1 | Predicted | AlphaFoldDB |
23 variants for P22933
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs13465106 | 4 | L>V | No | EVA | |
| rs3388736217 | 40 | W>* | No | EVA | |
| rs3388736217 | 40 | W>C | No | EVA | |
| rs3388740204 | 45 | D>N | No | EVA | |
| rs13465107 | 53 | R>L | No | EVA | |
| rs3388733541 | 70 | L>I | No | EVA | |
| rs3388725925 | 83 | M>K | No | EVA | |
| rs3394970216 | 96 | R>Q | No | EVA | |
| rs3394861861 | 96 | R>W | No | EVA | |
| rs3388745326 | 143 | L>P | No | EVA | |
| rs3388740490 | 145 | R>L | No | EVA | |
| rs3388736687 | 158 | I>F | No | EVA | |
| rs3388725946 | 162 | V>E | No | EVA | |
| rs3388739119 | 194 | Y>* | No | EVA | |
| rs3388729580 | 206 | L>M | No | EVA | |
| rs3388736614 | 224 | E>* | No | EVA | |
| rs3388735297 | 230 | S>L | No | EVA | |
| rs3388735321 | 237 | L>F | No | EVA | |
| rs3388740705 | 339 | K>R | No | EVA | |
| rs3388733194 | 344 | K>M | No | EVA | |
| rs3388733142 | 376 | I>M | No | EVA | |
| rs239162435 | 409 | P>A | No | EVA | |
| rs3388736649 | 412 | I>F | No | EVA |
No associated diseases with P22933
3 regional properties for P22933
12 GO annotations of cellular component
| Name | Definition |
|---|---|
| anchoring junction | A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix. |
| axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| chloride channel complex | An ion channel complex through which chloride ions pass. |
| dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| GABA-A receptor complex | A protein complex which is capable of GABA-A receptor activity. In human, it is usually composed of either two alpha, two beta and one gamma chain of the GABA-A receptor subunits or 5 chains of the GABA-A receptor subunits rho1-3 (formally known as GABA-C receptor). |
| GABA-ergic synapse | A synapse that uses GABA as a neurotransmitter. These synapses are typically inhibitory. |
| glutamatergic synapse | A synapse that uses glutamate as a neurotransmitter. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| integral component of postsynaptic membrane | The component of the postsynaptic membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| synapse | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| chloride channel activity | Enables the facilitated diffusion of a chloride (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. |
| excitatory extracellular ligand-gated ion channel activity | Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular ligand has been bound by the channel complex or one of its constituent parts, where channel opening contributes to an increase in membrane potential. |
| GABA-A receptor activity | Combining with the amino acid gamma-aminobutyric acid (GABA, 4-aminobutyrate) to initiate a change in cell activity. GABA-A receptors function as chloride channels. |
| neurotransmitter receptor activity | Combining with a neurotransmitter and transmitting the signal to initiate a change in cell activity. |
| transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential | Any transmitter-gated ion channel activity that is involved in regulation of postsynaptic membrane potential. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| chemical synaptic transmission | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. |
| chloride transmembrane transport | The process in which chloride is transported across a membrane. |
| ion transmembrane transport | A process in which an ion is transported across a membrane. |
| nervous system process | A organ system process carried out by any of the organs or tissues of neurological system. |
| regulation of membrane potential | Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. |
| signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
14 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q9UN88 | GABRQ | Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (Human) | PR |
| O14764 | GABRD | Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (Human) | PR |
| Q91XP5 | Glra3 | Glycine receptor subunit alpha-3 | Mus musculus (Mouse) | PR |
| P62812 | Gabra1 | Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (Mouse) | PR |
| P48168 | Glrb | Glycine receptor subunit beta | Mus musculus (Mouse) | PR |
| P22723 | Gabrg2 | Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (Mouse) | PR |
| P23979 | Htr3a | 5-hydroxytryptamine receptor 3A | Mus musculus (Mouse) | PR |
| P09690 | Chrnb1 | Acetylcholine receptor subunit beta | Mus musculus (Mouse) | PR |
| Q9R0W9 | Chrna6 | Neuronal acetylcholine receptor subunit alpha-6 | Mus musculus (Mouse) | PR |
| Q8BMN3 | Chrnb3 | Neuronal acetylcholine receptor subunit beta-3 | Mus musculus (Mouse) | PR |
| Q2MKA5 | Chrna5 | Neuronal acetylcholine receptor subunit alpha-5 | Mus musculus (Mouse) | PR |
| P04756 | Chrna1 | Acetylcholine receptor subunit alpha | Mus musculus (Mouse) | PR |
| Q64018 | Glra1 | Glycine receptor subunit alpha-1 | Mus musculus (Mouse) | PR |
| G5ECJ0 | exp-1 | Gamma-aminobutyric acid receptor exp-1 | Caenorhabditis elegans | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDVLGWLLLP | LLLLCTQPHH | GARAMNDIGD | YVGSNLEISW | LPNLDGLMEG | YARNFRPGIG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GAPVNVALAL | EVASIDHISE | ANMEYTMTVF | LHQSWRDSRL | SYNHTNETLG | LDSRFVDKLW |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LPDTFIVNAK | SAWFHDVTVE | NKLIRLQPDG | VILYSIRITS | TVACDMDLAK | YPLDEQECML |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DLESYGYSSE | DIVYYWSENQ | EQIHGLDRLQ | LAQFTITSYR | FTTELMNFKS | AGQFPRLSLH |
| 250 | 260 | 270 | 280 | 290 | 300 |
| FQLRRNRGVY | IIQSYMPSVL | LVAMSWVSFW | ISQAAVPARV | SLGITTVLTM | TTLMVSARSS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LPRASAIKAL | DVYFWICYVF | VFAALVEYAF | AHFNADYRKK | RKAKVKVTKP | RAEMDVRNAI |
| 370 | 380 | 390 | 400 | 410 | 420 |
| VLFSLSAAGV | SQELAISRRQ | GRVPGNLMGS | YRSVEVEAKK | EGGSRPGGPG | GIRSRLKPID |
| 430 | 440 | ||||
| ADTIDIYARA | VFPAAFAAVN | IIYWAAYTM |